I just revisited the 1/31/16 Zenith financials. At that time, Zenith was in a cash pinch with ~ 24,000 USD's on hand - that is $24 thousand. Note 3 to the financials, entitled "Going Concern" disclosed the risks and warned that without an infusion of working capital the company did not have sufficient funds to continue as a going concern and meet its obligations. Since that time, the company has commenced two trials. Until the April 30th financials are released, we will not know the exact #s, however IMHO - at 1/31/16 the burn rate was .5mil per mo to fund operations - add another mil or more per mo for the trials, and this ~ 24mil infusion might buy another 12-18 mos. of operations. Both companies need cash or partners to continue research and proof of concept. I would hope that one of the anticipated catalysts would illuminate this opportunity and lift the share price for an IPO. The end game is closing and we desperately need some promising results and affirmation.

Still long and patient

Chicagoest